FDA Drug Application (020192) for LAMISIL by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020192
Product Number001
FormCREAM;TOPICAL
Dosage1%
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMISIL
Active IngredientTERBINAFINE HYDROCHLORIDE



Back to FDA Applications sponsored by NOVARTIS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.